Akebia Chief Commercial Officer Nicholas Grund to Resign Nov. 6
Nicholas Grund will resign as Akebia Therapeutics’ senior vice president and chief commercial officer effective November 6, 2026, and serve as a consultant through April 30, 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Akebia Therapeutics Chief Commercial Officer Nicholas Grund resigns effective Nov. 6
Akebia Therapeutics’ Senior Vice President and Chief Commercial Officer Nicholas Grund resigned for personal reasons, effective Nov. 6, 2026. Grund is set to provide consulting and advisory services to the company from his departure date through April 30, 2027. The consulting arrangement allows for early termination wi